New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Oscar Health, Inc.
OSCR
Shape
US Flag

NYSE

Unprofitable

Unprofitable

4B

Medical - Healthcare Plans

Next Earning date - 05 Nov 2024

4B

Medical - Healthcare Plans

Next Earning date - 05 Nov 2024

20.14USD
Shape0.95 ( 4.95%)
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

-7%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated October 7, 2024
1W -2.38 % 1M 15.28 % 3M 24.86 % 1Y 280.72 %

Key Metrics

Shape
  • Market Cap

    4.16B


  • Shares Outstanding

    206.40M


  • Share in Float

    173.22M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    20.14


  • Average Volume

    2.93M


  • Beta

    1.623


  • Range

    4.72-23.79


  • Industry

    Medical - Healthcare Plans


  • Website

    https://www.hioscar.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.57x

P/S Ratio

4.22x

P/B Ratio

0.3

Debt/Equity

0.3%

Net Margin

$-0.1

EPS

How OSCR compares to sector?

P/E Ratio

Relative Strength

Shape

OSCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11B

Shape408%

2025-Revenue

$0.66

Shape173%

2025-EPS

$4B

Shape-51629%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Not converted

2024-06-25

Now: Overweight

Bank of America Securities

upgrade

Previous: Not converted

2023-06-06

Now: Neutral

Wells Fargo

upgrade

Previous: Not converted

2022-11-15

Now: Overweight

Morgan Stanley

downgrade

Previous: Overweight

2022-11-14

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.91
vs -1.02

Q4.22

arrow
arrow

N/A

-1.05
vs -0.95

Q1.23

arrow
arrow

N/A

-0.18
vs -0.36

Q2.23

arrow
arrow

N/A

-0.07
vs -0.53

Q3.23

arrow
arrow

N/A

-0.29
vs -0.91

Q4.23

arrow
arrow

N/A

-0.66
vs -1.05

Q1.24

arrow
arrow

+444%

0.62
vs -0.18

Q2.24

arrow
arrow

+386%

0.2
vs -0.07

Q3.24

arrow
arrow

N/A

-0.17
vs -0.29

Q4.24

arrow
arrow

N/A

-0.57
vs -0.66

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-91%

40.1M  vs 462.2M

Q4.22

arrow
arrow

+99%

1B  vs 520.3M

Q1.23

arrow
arrow

+45%

1.5B  vs 1B

Q2.23

arrow
arrow

+44%

1.5B  vs 1.1B

Q3.23

arrow
arrow

+3492%

1.4B  vs 40.1M

Q4.23

arrow
arrow

+38%

1.4B  vs 1B

Q1.24

arrow
arrow

+46%

2.1B  vs 1.5B

Q2.24

arrow
arrow

+46%

2.2B  vs 1.5B

Q3.24

arrow
arrow

+61%

2.3B  vs 1.4B

Q4.24

arrow
arrow

+63%

2.3B  vs 1.4B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-18%

-0.18
vs -0.09

Q4.22

arrow
arrow

-25%

-0.25
vs -0.18

Q1.23

arrow
arrow

-4%

-0.04
vs -0.25

Q2.23

arrow
arrow

-2%

-0.02
vs -0.04

Q3.23

arrow
arrow

-7%

-0.07
vs -0.02

Q4.23

arrow
arrow

-19%

-0.19
vs -0.07

Q1.24

arrow
arrow

+17%

0.17
vs -0.19

Q2.24

arrow
arrow

+5%

0.05
vs 0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

135

135
vs 135

NA

Q4.22

arrow
arrow

134

134
vs 135

-1%

Q1.23

arrow
arrow

135

135
vs 134

1%

Q2.23

arrow
arrow

168

168
vs 135

24%

Q3.23

arrow
arrow

183

183
vs 168

9%

Q4.23

arrow
arrow

197

197
vs 183

8%

Q1.24

arrow
arrow

234

234
vs 197

19%

Q2.24

arrow
arrow

279

279
vs 234

19%

Earnings Growth

Latest News